Dr. William D. Picking's lab at the University of Missouri-Columbia focuses on understanding how the Shigella bacterium can cause severe intestinal disease. By studying the structure and function of a specialized mechanism used by the bacteria to inject harmful proteins into human cells, the lab hopes to uncover ways to block this process. This research not only aims to shed light on a major public health issue but also seeks to develop new treatments for infections like shigellosis, particularly in vulnerable populations such as young children.

Dr. Dragana Rogulja's lab at Harvard Medical School investigates how the gut signals to the brain to influence sleep quality and arousability. The research focuses on the role of nutrients, particularly dietary proteins, in regulating the depth of sleep without affecting its duration. By studying Drosophila (fruit flies), the lab aims to better understand the mechanisms of sleep regulation, which could ultimately inform treatments for sleep disorders in humans.

Dr. Yevgenia Kozorovitskiy's lab at Northwestern University studies how brains of different rodent species synchronize their neural activity during social interactions. By using advanced genetic and optical tools, they explore the mechanisms behind this synchronization and how it affects social behaviors, which can provide insights into human social interactions and mental health. The research aims to understand how these inter-brain dynamics shape social behavior and attachment, which could have significant therapeutic implications.

Dr. Polina Lishko's lab at Washington University focuses on understanding how sperm function is regulated, particularly through a calcium channel called CatSper, which is critical for male fertility. The lab studies how environmental factors like temperature and certain chemicals influence sperm motility and capacitation—the process that enables sperm to fertilize an egg. Their research has important implications for addressing male infertility issues, such as those associated with varicocele, a condition that can impair sperm function.

Dr. Jere McBride's research focuses on understanding how the intracellular bacterium Ehrlichia chaffeensis, which causes a serious tick-borne disease in humans, manipulates host cell machinery to enhance its survival and replication. The lab investigates the role of specific proteins that Ehrlichia secretes to alter RNA splicing processes in human cells, particularly those involved in immune responses. By exploring these molecular interactions, the research aims to uncover new therapeutic strategies to combat this pathogen and similar intracellular infections.

Chaolin Zhang's research lab at Columbia University focuses on understanding how RNA molecules and their binding proteins regulate gene expression, especially in the brain. They study alternative splicing, a process that generates diverse proteins from a single gene, which is crucial for the function of different neuronal cell types. Their work aims to map regulatory elements that control this splicing and investigate how alterations in these processes can lead to neurological disorders and other diseases.

Dr. Eric Huseby's lab focuses on understanding how genetic variations in immune system genes influence the development and function of T cells involved in type 1 diabetes (T1D). By studying specific mouse models, the lab aims to uncover the processes that lead to autoimmune destruction of insulin-producing cells in the pancreas. This research could help develop better diagnostic tools and therapeutic strategies for T1D and other autoimmune diseases.

Dr. Marco Gallio's lab at Northwestern University focuses on understanding how temperature is sensed and processed in the brain using fruit flies (Drosophila). They investigate the neural circuits and mechanisms that determine how flies differentiate between hot, cold, and noxious temperatures, and how these perceptions influence behavior. By studying these processes, the lab aims to uncover fundamental principles of sensory processing that may apply to more complex organisms, including humans.

Dr. Adrian Erlebacher's lab at UCSF focuses on understanding how the fetus and placenta evade rejection by the maternal immune system. They investigate the role of glycosylated proteins on the surface of the placenta in modulating immune responses, which has implications for pregnancy complications like preeclampsia and miscarriage. Their research combines animal models and human samples to explore these mechanisms and aims to open new avenues for developing immune tolerance therapies.

Dr. Stephen Tymanskyj's lab at Augusta University focuses on understanding how intracellular transport works in neurons, especially in relation to neurodevelopmental and neurodegenerative diseases. The team is developing a novel optogenetic method that uses artificially created cargo to study motor proteins and their role in transporting materials within neurons. This research aims to uncover the fundamental mechanisms of transport processes and how they are affected by genetic mutations linked to disorders like autism and Parkinson's disease.

The lab led by Dr. Randall J. Roper focuses on understanding the genetic factors that influence Down syndrome (DS) traits. They specifically look at how different genes, including those not directly associated with DS, can affect physical and cognitive characteristics in individuals with Down syndrome. Their work involves creating advanced mouse models to better represent the variety of symptoms seen in humans with trisomy 21, particularly investigating how factors like sex and skeletal development might modify these traits.

Dr. Catherine Denicourt's lab at the University of Texas Health Science Center in Houston focuses on understanding how modifications to transfer RNA (tRNA) influence the process of mRNA translation, especially under stress conditions. They study a specific enzyme involved in tRNA modification and its role in cellular responses to stress, aiming to uncover how these mechanisms affect gene expression and cellular health. This research may have significant implications for understanding diseases linked to tRNA dysfunction.

Dr. Rey A Carabeo's lab at the University of Nebraska Medical Center studies the bacterium Chlamydia trachomatis, which causes infections and relies on host cells for nutrients. The lab focuses on understanding how this pathogen regulates its metabolic processes, specifically the tryptophan biosynthesis pathway, to survive in different environments. They investigate gene expression regulation, aiming to uncover new insights into the bacterial adaptation mechanisms in response to nutrient availability.

The lab of Dr. Jeffrey W. Harper at Harvard Medical School focuses on understanding how a class of proteins called Cullin-Ring E3 ubiquitin ligases (CRLs) control various biological processes, including the cell cycle and stem cell differentiation. By using genetic and biochemical methods, the lab aims to uncover how these ligases target specific proteins for degradation, a crucial process for maintaining cellular function and integrity. Their research may reveal important insights into development, aging, and cancer biology, potentially leading to new therapeutic strategies.

Dr. Seyed Ali Mortazavi's lab focuses on understanding the influence of genetic variants on gene expression and functionality in mouse models. By analyzing diverse mouse strains at the single-cell level, the lab aims to create a comprehensive resource that maps how these variants affect different cell types across various tissues. This research is crucial for developing better models of human diseases and for enhancing our understanding of genetics in health and complex diseases.

Dr. Ming He's lab at the University of Alabama at Birmingham focuses on how certain modifications to histone proteins in endothelial cells (the cells lining blood vessels) contribute to cardiovascular diseases, particularly under conditions of diabetes and abnormal blood flow. By exploring these novel histone modifications, the lab aims to uncover mechanisms that lead to endothelial dysfunction and accelerated atherosclerosis. The research combines cell culture techniques with mouse models to investigate the impacts of these modifications on health and disease.

Dr. Vivek Nanda's research lab at the University of Alabama at Birmingham focuses on understanding the molecular mechanisms behind peripheral artery disease (PAD), a serious cardiovascular condition. The lab investigates a specific gene, Leiomodin 1, to explore its role in the formation of mature blood vessels, which is crucial for restoring blood flow in patients with PAD. By studying the effects of this gene on smooth muscle cells, the lab aims to develop strategies and therapies that could improve treatment outcomes for individuals suffering from PAD.

Dr. Thomas Hope's lab at Northwestern University focuses on understanding how HIV persists in the body despite treatment. They study the role of specific immune cells, especially myeloid cells, in supporting virus survival and contributing to viral rebound when treatment stops. By using advanced imaging techniques and working with animal models, they aim to identify the main targets of HIV in tissues, which can help in developing new strategies for curing HIV and preventing transmission.

Dr. Heinrich Gottlinger's lab at the University of Massachusetts Med School focuses on understanding how a cellular enzyme called ADAM10 interacts with the HIV virus. Their research aims to uncover how ADAM10 influences HIV replication and infection by shedding viral proteins from the surface of the virus. This work could lead to new strategies for targeting HIV and preventing its spread.

Dr. James P. Luyendyk's lab studies how the blood protein von Willebrand Factor (VWF) affects the repair of liver injuries caused by an overdose of acetaminophen, a common pain medication. They aim to discover ways to enhance liver recovery by targeting VWF and its interactions with platelets. The lab works closely with a network of physician-scientists and utilizes advanced genetic models and therapeutic strategies to address acute liver failure, which currently has limited treatment options.